Golimumab (Subcutaneous Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Golimumab (Subcutaneous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Simponi

Description

Golimumab injection is used to treat the symptoms of moderate-to-severe rheumatoid arthritis and ankylosing spondylitis (arthritis in the spine or backbone). It is also used to treat psoriatic arthritis, which is a type of arthritis that causes pain and swelling in the joints along with patches of scaly skin on some areas of the body. Psoriatic arthritis usually occurs with a skin condition called psoriasis. Golimumab may be used alone or in combination with other arthritis medicines, such as methotrexate (Rheumatrex®, Trexall®), sulfasalazine (Azulfidine®), hydroxychloroquine (Plaquenil®), corticosteroids (cortisone-like medicines), or nonsteroidal antiinflammatory drugs (NSAIDs).

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

  • Solution
Before Using
DR602971 Portions of this document last updated: Feb. 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger